Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA PROCTER & GAMBLE HEALTH DISHMAN PHARMA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 30.0 34.5 87.0% View Chart
P/BV x 3.3 10.5 31.8% View Chart
Dividend Yield % 0.7 2.0 32.9%  

Financials

 DISHMAN PHARMA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
PROCTER & GAMBLE HEALTH
Jun-23
DISHMAN PHARMA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs3745,366 7.0%   
Low Rs1293,883 3.3%   
Sales per share (Unadj.) Rs197.0740.7 26.6%  
Earnings per share (Unadj.) Rs21.2138.2 15.3%  
Cash flow per share (Unadj.) Rs34.7155.2 22.4%  
Dividends per share (Unadj.) Rs2.0095.00 2.1%  
Avg Dividend yield %0.82.1 38.7%  
Book value per share (Unadj.) Rs179.9447.6 40.2%  
Shares outstanding (eoy) m80.7016.60 486.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.36.2 20.5%   
Avg P/E ratio x11.933.5 35.5%  
P/CF ratio (eoy) x7.329.8 24.3%  
Price / Book Value ratio x1.410.3 13.5%  
Dividend payout %9.468.7 13.7%   
Avg Mkt Cap Rs m20,30776,761 26.5%   
No. of employees `000NANA-   
Total wages/salary Rs m5,3552,062 259.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,89812,296 129.3%  
Other income Rs m265184 144.3%   
Total revenues Rs m16,16312,480 129.5%   
Gross profit Rs m4,1033,247 126.4%  
Depreciation Rs m1,091281 388.1%   
Interest Rs m9448 12,264.9%   
Profit before tax Rs m2,3343,142 74.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m624847 73.6%   
Profit after tax Rs m1,7102,295 74.5%  
Gross profit margin %25.826.4 97.7%  
Effective tax rate %26.727.0 99.1%   
Net profit margin %10.818.7 57.6%  
BALANCE SHEET DATA
Current assets Rs m11,01811,713 94.1%   
Current liabilities Rs m9,5176,791 140.1%   
Net working cap to sales %9.440.0 23.6%  
Current ratio x1.21.7 67.1%  
Inventory Days Days57263 21.7%  
Debtors Days Days3343 1.0%  
Net fixed assets Rs m18,78710,617 177.0%   
Share capital Rs m161166 97.2%   
"Free" reserves Rs m14,3547,265 197.6%   
Net worth Rs m14,5167,431 195.4%   
Long term debt Rs m4,1890-   
Total assets Rs m29,80522,330 133.5%  
Interest coverage x3.5409.1 0.8%   
Debt to equity ratio x0.30-  
Sales to assets ratio x0.50.6 96.9%   
Return on assets %8.910.3 86.4%  
Return on equity %11.830.9 38.1%  
Return on capital %17.542.4 41.3%  
Exports to sales %24.90-   
Imports to sales %3.713.1 28.6%   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m5941,605 37.0%   
Fx inflow Rs m4,9521,465 337.9%   
Fx outflow Rs m6971,605 43.4%   
Net fx Rs m4,255-140 -3,034.8%   
CASH FLOW
From Operations Rs m2,7862,360 118.1%  
From Investments Rs m-1,529-215 711.1%  
From Financial Activity Rs m-941-985 95.6%  
Net Cashflow Rs m3171,160 27.3%  

Share Holding

Indian Promoters % 61.4 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 23.0 20.3 113.3%  
FIIs % 12.0 7.6 157.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 48.2 80.1%  
Shareholders   52,291 56,730 92.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Procter & Gamble Health Share Price Performance

Period Dishman Pharma Procter & Gamble Health S&P BSE HEALTHCARE
1-Day 2.87% -0.55% 1.18%
1-Month -2.45% -7.47% -0.75%
1-Year 96.38% -3.02% 61.82%
3-Year CAGR 89.34% -9.12% 18.16%
5-Year CAGR 38.20% 5.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.